Anti-Human TCR Recombinant Antibody (BMA 031) (CAT#: TAB-545CT)

1. Q 1: Can this antibody be used in flow cytometry?

   A: Yes, the Anti-TCR Therapeutic Antibody is suitable for flow cytometry applications. It can bind to T-cell receptors on live or fixed cells, allowing researchers to identify and analyze different T-cell populations based on TCR expression. This is helpful for studying immune cell distributions and functions in research studies.

2. Q 2: Can this antibody be used to study autoimmune diseases?

   A: Yes, researchers can use this antibody to study autoimmune conditions in experimental models. By targeting the T-cell receptor, it helps investigate how T cells contribute to autoimmune reactions. This can provide insights into disease mechanisms and aid in the development of new research strategies for autoimmune diseases.

3. Q 3: Can this antibody help in cancer immunology research?

   A: Yes, this antibody is valuable in cancer immunology studies. By targeting T-cell receptors, it allows researchers to explore how T cells recognize and respond to cancer cells. This can provide insights into immune surveillance mechanisms and contribute to the development of immunotherapy research strategies.

View the frequently asked questions answered by Creative Biolabs Support.